Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > VERA Vera Therapeutics > Detailed Quotes

VERA Vera Therapeutics

Watchlist
8.740
-0.400-4.38%
Close  01/27 16:00 ET
8.550
-0.190-2.17%
Post Mkt Price 01/27 19:58 ET
High
9.510
Open
9.150
Turnover
4.31M
Low
8.480
Pre Close
9.140
Volume
492.85K
Market Cap
241.73M
P/E(TTM)
Loss
52wk High
24.980
Shares
27.66M
P/E(Static)
Loss
52wk Low
5.200
Float Cap
105.09M
Bid/Ask %
0.00%
Historical High
37.110
Shs Float
12.02M
Volume Ratio
0.94
Historical Low
5.200
Dividend TTM
--
Div Yield TTM
--
P/B
2.29
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
4.10%
Amplitude
11.27%
Avg Price
8.746
Lot Size
1
Float Cap
105.09M
Bid/Ask %
0.00%
Historical High
37.110
Shs Float
12.02M
Volume Ratio
0.94
Historical Low
5.200
Dividend TTM
--
P/B
2.29
Dividend LFY
--
Turnover Ratio
4.10%
Amplitude
11.27%
Avg Price
8.746
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Vera Therapeutics, Inc. is a clinical stage biotechnical company that engages in the development and commercialization of transformative treatments for immunological diseases. Its primary product, atacicept, is a fusion protein self-administered as a subcutaneous injection that blocks both B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.
CEO: Dr. Marshall Fordyce, M.D.
Market: NASDAQ
Listing Date: 05/14/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist